Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on FormF-3 of our report dated April 29, 2019, relating to the consolidated financial statements of ASLAN Pharmaceuticals Limited and its subsidiaries (the “Group”), appearing in the Annual Report on Form20-F and of the Group for the year ended December 31, 2018, and to the reference to us under the heading “Experts” in the prospectus, which is part of this Registration Statement.
/S/ Deloitte & Touche
Deloitte & Touche
Taipei, Taiwan
Republic of China
October 31, 2019